Navigation Links
Delcath Systems to Report Third Quarter Progress and Conduct Conference Call
Date:10/28/2011

NEW YORK, Oct. 28, 2011 /PRNewswire/ -- Delcath Systems, Inc. (Nasdaq: DCTH) announced that it will host a conference call and webcast to discuss its recent corporate developments and update its progress on Monday, November 7, 2011 at 4:30 p.m. ET.  Eamonn Hobbs, President and Chief Executive Officer will host the call.

The dial-in number for the conference call is 800-322-5044 for domestic participants and 617-614-4927 for international participants, both using passcode 65515511.

To access the live webcast of the meeting, go to Delcath's website at www.delcath.com. A taped replay of the conference call will also be available beginning approximately two hours after the call's conclusion and will be available for seven days. This replay can be accessed by dialing 888-286-8010 for domestic callers and 617-801-6888 for international callers, both using passcode 65413528. An archived webcast will also be available at www.delcath.com.

About Delcath SystemsDelcath Systems, Inc. is a development stage specialty pharmaceutical and medical device company focused on oncology. Delcath's proprietary system for chemosaturation is designed to administer high dose chemotherapy and other therapeutic agents to diseased organs or regions of the body, while controlling the systemic exposure of those agents. The Company's initial focus is on the treatment of primary and metastatic liver cancers. In 2010, Delcath concluded a Phase III metastatic melanoma study, and the Company recently completed a multi-arm Phase II trial to treat other liver cancers. The Company obtained authorization to affix a CE Mark for the Hepatic CHEMOSAT delivery system in April 2011. The Company has not yet received FDA approval for c
'/>"/>

SOURCE Delcath Systems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. FDA Schedules Delcath Pre-New Drug Application Meeting Date
2. Delcath Announces Completion of Regulatory Notification Process in New Zealand
3. Delcath Announces Updated Efficacy Results From Phase 3 Trial of Chemosaturation for Melanoma Metastases in the Liver Presented at European Multidisciplinary Cancer Congress
4. Delcath to Present at the JMP Securities Healthcare Conference on September 28, 2011
5. Delcath Systems, Inc. Hosts Symposium on Chemosaturation at CIRSE Annual Meeting
6. Delcath Announces Top-Line Results From Metastatic Colorectal Cohort in Phase II Trial of Chemosaturation System
7. Delcath Announces Encouraging Top-Line Results From Hepatobiliary Cohort in Phase II Trial of Chemosaturation System
8. Delcath to Present at the Wedbush 2011 Life Sciences Conference on August 16, 2011
9. Delcath Systems to Report Second Quarter Progress Update and Conduct Conference Call
10. Delcath Systems, Inc. Announces the Completion of Common Stock Offering
11. Delcath Systems, Inc. Announces the Sale of 5,000,000 Shares of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... 2014 Asterias Biotherapeutics, Inc. (OTCBB: ASTY), a ... medicine, announced today the appointments of Andrew ("Andy") Arno ... Board of Directors. With these additions, the Asterias Board ... are independent. Andy Arno , 55, ... companies. He is currently Managing Director of Emerging Growth ...
(Date:8/20/2014)... 20, 2014  The National Association of Drug ... achieved by the real-time, pseudoephedrine (PSE) blocking system ... Log Exchange (NPLEx), automatically blocks unlawful PSE sales ... offenders and make arrests. Data released by NPLEx ... blocked the sale of more than 23,478 ...
(Date:8/20/2014)... PLAINFIELD, N.J. , Aug. 20, 2014 PTC Therapeutics, ... will participate at two upcoming investor conferences: - ... Seasons Hotel in Boston on Wednesday, ... Biotech Conference at The Mandarin Oriental Boston on Thursday, September ... present a company update at the Bank of America Merrill ...
Breaking Medicine Technology:Asterias Biotherapeutics Appoints Two Independent Directors and Announces Completion of Series A Common Stock Distribution 2Asterias Biotherapeutics Appoints Two Independent Directors and Announces Completion of Series A Common Stock Distribution 3Asterias Biotherapeutics Appoints Two Independent Directors and Announces Completion of Series A Common Stock Distribution 4Kentucky's Stop-Sale System Achieves Significant Results In Battle Against Meth 2PTC Therapeutics to Participate at Upcoming Investor Conferences 2
(Date:8/21/2014)... Top10BestSEOHosting.com has recently compared many professional ... http://www.top10bestseohosting.com/go/iPage/ ) is one of the best cheap ... manager of Top10BestSEOHosting.com states, “It is hard to ... companies have outperformed their competitors on hosting features, ... get the best web hosting at affordable prices.” ...
(Date:8/21/2014)... Today, Zane Benefits, the #1 Online Health ... credits in 2015. , According to Zane Benefits, premium ... Affordable Care Act (ACA), premium tax credits are available ... through the Health Insurance Marketplaces. , The new article ... of the tax credits, updated for 2015. , ...
(Date:8/21/2014)... NY (PRWEB) August 21, 2014 ... trend among their patients. Alternative medicine is on ... due to millenials. According to The Fiscal Times, ... medical treatments over conventional medicine. , The Fiscal ... how many millenials are embracing alternative medicine. The ...
(Date:8/21/2014)... For many people, finding motivation to exercise is a challenge. ... the approach of Zombies, Run!one of more than 31,000 health ... the growing number of apps that use games to increase ... mobile fitness app makers looking to cash in to help ... to exercise remains to be seen. , "It,s just been ...
(Date:8/21/2014)... 2014 Improv performers from Fun House ... dementia at Silverado Turtle Creek memory care community in ... entertainers ranging from ages 10 to 16, delivers a ... 40-minute set. The troupe's philosophy is that improv is ... them to touch audiences regardless of their circumstance — ...
Breaking Medicine News(10 mins):Health News:iPage Reviews Unveiled Online At Top10BestSEOHosting.com 2Health News:Van Uden Center Sees Growth in Alternative Medicine 2Health News:Playing hunger games: Are gamified health apps putting odds in your favor? 2Health News:Unicorn Clearance Improv Troupe Brings Laughter to Residents with Dementia at Silverado Memory Care 2
... MONDAY, April 4 (HealthDay News) -- Taking aspirin even once ... associated with a marked drop in the risk of developing ... once monthly was linked to a 26 percent reduction in ... the risk of heart disease, was associated with an even ...
... Prostate cancer is the second leading cause of cancer-related death ... reduced the number of deaths from the disease. By ... risk for aggressive disease or diagnosis at a young age, ... screening approach. For that reason, scientists have been looking for ...
... , SUNDAY, April 3 (HealthDay News) -- ... of heart attack four years after the city was ... Chronic stress, not being able to return home ... this situation, said the researchers, who updated their two-year ...
... metabolic syndrome, a constellation of conditions that increases the ... the risk of the two most common types of ... 102nd Annual Meeting 2011, held here April 2-6. ... National Cancer Institute, said approximately one-third of the U.S. ...
... SUNDAY, April 3 (HealthDay News) -- The use of ... dramatically in the United States over the past five ... of these drugs -- widely regarded as the last ... -- is cause for concern because carbapenem-resistant bacteria are ...
... of New Ulm Project, which is merging environmental, peer ... community with the assistance of a healthcare system, worksites ... has shown a 24 percent reduction in the number ... with the previous five-quarter period of evaluation., This study ...
Cached Medicine News:Health News:Monthly Aspirin Use Linked to Lower Pancreatic Cancer Risk 2Health News:Monthly Aspirin Use Linked to Lower Pancreatic Cancer Risk 3Health News:MicroRNA variations associated with earlier prostate cancer diagnosis in African-American men 2Health News:Heart Attack Risk Plagues Post-Katrina New Orleans 2Health News:Metabolic syndrome may increase risk for liver cancer 2Health News:Research Warns of Overuse of Powerful Class of Antibiotics 2Health News:Regional prevention project involving 10,000 adults cuts heart attacks by 25 percent 2Health News:Regional prevention project involving 10,000 adults cuts heart attacks by 25 percent 3
BioSoft alcohol gel hand antiseptic with soothing moisturizers is a fast-acting, broad-spectrum antimicrobial solution. BioSoft alcohol gel hand antiseptic applies easily, requires no rinsing and dri...
... Scrub Care povidone-iodine (PVP-I) antimicrobial solutions ... control in all hospital and health-care settings. ... gel have a broad spectrum of activity, ... bacteria that may cause infection. The new ...
... hand sanitizers like Aplicare No Rinse Isopropyl ... as the recommended product for hand disinfection ... Guidelines for hand hygiene., According to the ... be prevented with better infection control programs. ...
This is long known for its purity and mildness, Castile Soap is also an effective cleaning agent that is used in a variety of applications. It rinses clean while leaving the skin soft and healthy....
Medicine Products: